Issue 12 | February 2024
On Leap Day, Here’s Your February Seuss+ Newsletter
Leap day is a relatively rare occurrence in our calendars, so it’s fitting that it’s also Rare Disease Day. For many of the life science companies we work with, rare diseases are the target of innovative treatments, but many of the approaches they’re harnessing could apply to any therapeutic area. In this issue, we highlight some rare disease news, as well as sharing some great Seuss+ courses for biotechs and CROs you might have missed. Happy reading!
Rare Diseases in the Spotlight
Sign Up for FDA Rare Disease Day
Clinical trials for rare disease interventions can be challenging, from navigating egal requirements to recruiting participants. To mark Rare Disease Week, the FDA is holding a virtual public meeting on March 1, 2024, discussing topics such as the FDA’s legal framework, what the FDA does during review processes, and their latest initiatives to advance medical product development for rare diseases. Sign up here >
How Could Harnessing Innovation Help Tackle Rare Diseases?
Rare diseases affect about 300 million people worldwide, but by definition, fewer than 200,000 people are diagnosed with each of them. Researchers need to take innovative approaches to tackling rare diseases, and some of the latest developments, inluding digital technologies like artificial intelligence (AI), and individualized therapies, are helping life science companies get closer to effective treatments. Read more from the Mayo Clinic >
Insights via Your Inbox
领英推荐
BIOTECH: Transformative Leadership Development: Beyond Generic training for Biotech and Pharma leader success
Are you a biotech or pharma leader looking to create a transformative leadership training strategy? In this free four-day email course, you can equip yourself with the tools to build and embed a holistic leadership development approach that will drive success in your organization. Ready to get started? Sign up here >
CRO: Unlock Your CRO’s Success at Life Science Industry Events
As spring emerges, you might be preparing to put your organization out there at this year’s industry events. Make the most of your presence with this free four-day email course, in which you’ll learn how to boost your ROI from events, enhance your marketing efforts, generate valuable leads, and network effectively. Sign up here >
About Seuss+
Seuss+ is a collaborative and trusted international life science consultancy. We creatively solve complex business challenges so our clients can focus on what they do best—science. We support drug development program success and organizational growth through our unique partner approach and portfolio of tailored and strategic business solutions.